https://www.selleckchem.com/products/k02288.html
The overall pooled prevalence was 7.5% (95% CI 3.2-12.8) for maternal death, 10.6% (95% CI 6.0-16.3) for pregnancy loss, 12.9% (95% CI 0.0-38. for preterm birth and 23.7% (95% CI 17.0-31. for low birthweight. The findings suggest that MDR-TB is associated with a high risk of adverse maternal and perinatal outcomes, but these should be interpreted cautiously because the evidence is largely preliminary. Adequately powered prospective cohort studies are urgently required to corroborate these findings. Multidrug-resistant tuberculosis ma
Like
Comment
Share
